Nagy Fruzsina

1.

Jakab, Á., Kovács, F., Balla, N., Nagy-Köteles, C., Ragyák, Á., Nagy, F., Borman, A. M., Majoros, L., Kovács, R. L.: Comparative transcriptional analysis of Candida auris biofilms following farnesol and tyrosol treatment.
Microbiol. Spectr. 12 (4), 1-12, 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cell Biology

Q1 Ecology

Q2 Genetics

Q1 Infectious Diseases

Q1 Physiology

Q1 Immunology and Microbiology (miscellaneous)

Q1 Microbiology (medical)

2.

Kovács, F., Balla, N., Bozó, A., Harmath, A., Jakab, Á., Tóth, Z., Nagy, F., Majoros, L., Kovács, R. L.: Epidemiology, clinical characteristics, outcome and biofilm forming properties in candidaemia: a single-centre retrospective 4-year analysis from Hungary.
Mycoses. 67 (4), 1-12, (article identifier: 13727), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Dermatology

Q2 Infectious Diseases

Q1 Medicine (miscellaneous)

3.

Spengler, G., Gajdács, M., Donadu, M. G., Usai, M., Marchetti, M., Ferrari, M., Mazzarello, V., Zanetti, S., Nagy, F., Kovács, R. L.: Evaluation of the Antimicrobial and Antivirulent Potential of Essential Oils Isolated from Juniperus oxycedrus L. ssp. macrocarpa Aerial Parts.
Microorganisms. 10 (4), 1-20, (article identifier: 758), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Microbiology

Q2 Microbiology (medical)

Q2 Virology

4.

Kovács, R. L., Tóth, Z., Locke, J. B., Forgács, L., Kardos, G., Nagy, F., Borman, A. M., Majoros, L.: Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum.
Microorganisms. 9 (4), 1-12, (article identifier: 863), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Microbiology

Q2 Microbiology (medical)

Q3 Virology

5.

Nagy, F., Tóth, Z., Váradi, G., Tóth, L., Forgács, L., Vadászi, K., Majoros, L., Galgóczy, L., Kovács, R. L.: Echinocandinok és a Neosartorya fischeri antifungális fehérje 2 (NFAP2) kombinációjának in vitro vizsgálata Candida auris biofilmek ellen.
Acta Microbiol. Immunol. Hung. 68, 28-29, 2021.

DEA

6.

Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A. M., Majoros, L., Kovács, R. L.: In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.
Med. Mycol. 59 (10), 1015-1023, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Infectious Diseases

Q2 Medicine (miscellaneous)

D1 Veterinary (miscellaneous)

7.

Balázs, B., Nagy, J. B., Tóth, Z., Nagy, F., Károlyi, S., Turcsányi, I., Bistyák, A., Kálmán, A., Sárközi, R., Kardos, G.: Occurrence of Escherichia coli producing extended spectrum [béta]-lactamases in food-producing animals.
Acta Vet. Hung. 69 (3), 1-5, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Veterinary (miscellaneous)

8.

Jakab, Á., Emri, T., Csillag, K., Szabó, A., Nagy, F., Baranyai, E., Sajtos, Z., Géczi, D., Antal, K., Kovács, R. L., Szabó, K., Dombrádi, V., Pócsi, I.: The negative effect of protein phosphatase Z1 deletion on the oxidative stress tolerance of Candida albicans is synergistic with betamethasone exposure.
J. Fungi. 7 (540), 1-24, (article identifier: 540), 2021.

doi DEA WoS Scopus

Journal metrics:

Q1 Ecology, Evolution, Behavior and Systematics

Q1 Plant Science

Q2 Microbiology (medical)

9.

Kovács, R. L., Nagy, F., Tóth, Z., Forgács, L., Tóth, L., Váradi, G., Tóth, G. K., Vadászi, K., Borman, A. M., Majoros, L., Galgóczy, L.: The Neosartorya fischeri Antifungal Protein 2 (NFAP2): a New Potential Weapon against Multidrug-Resistant Candida auris Biofilms.
Int. J. Mol. Sci. 22 (2), 1-14, (article identifier: 771), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

Q1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

10.

Balázs, B., Tóth, Z., Nagy, F., Kovács, R. L., Tóth, H., Nagy, J. B., Tóth, Á., Szarka, K., Majoros, L., Kardos, G.: The Role of Uniform Meropenem Usage in Acinetobacter baumannii Clone Replacement.
Antibiotics. 10 (2), 1-12, (article identifier: 127), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Infectious Diseases

Q2 Pharmacology (medical)

Q2 Microbiology

Q2 Microbiology (medical)

Q1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

11.

Jakab, Á., Balla, N., Ragyák, Á., Nagy, F., Kovács, F., Sajtos, Z., Tóth, Z., Borman, A. M., Pócsi, I., Baranyai, E., Majoros, L., Kovács, R. L.: Transcriptional profiling of the Candida auris response to exogenous farnesol exposure.
mSphere. 6 (5), 1-12, (article identifier: 00710), 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Molecular Biology

Q1 Microbiology

12.

Kovács, R. L., Jakab, Á., Ragyák, Á., Sajtos, Z., Nagy, F., Baranyai, E., Pócsi, I., Majoros, L.: Transcriptomic approaches for the farnesol exposure of Candida auris.
Acta Microbiol. Immunol. Hung. 68, 85, 2021.

DEA

13.

Vitális, E., Nagy, F., Tóth, Z., Forgács, L., Bozó, A., Kardos, G., Majoros, L., Kovács, R. L.: Candida biofilm production is associated with higher mortality in patients with candidaemia.
Mycoses. 63 (4), 352-360, 2020.

doi DEA

Journal metrics:

Q1 Dermatology

Q2 Infectious Diseases

Q1 Medicine (miscellaneous)

14.

Nemes, D., Kovács, R. L., Nagy, F., Tóth, Z., Herczegh, P., Borbás, A., Kelemen, V., Pfliegler, V. P., Rebenku, I., Hajdu, P., Fehér, P., Ujhelyi, Z., Fenyvesi, F., Váradi, J., Vecsernyés, M., Bácskay, I.: Comparative biocompatibility and antimicrobial studies of sorbic acid derivates.
Eur. J. Pharm. Sci. 143, 1-9, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

15.

Forgács, L., Borman, A. M., Prépost, E., Tóth, Z., Kardos, G., Kovács, R. L., Székely, A., Nagy, F., Kovács, I., Majoros, L.: Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model.
Emerg. Microbes Infect. 9 (1), 1160-1169, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Drug Discovery

Q1 Epidemiology

Q1 Immunology

D1 Infectious Diseases

D1 Medicine (miscellaneous)

Q1 Microbiology

D1 Parasitology

Q1 Virology

16.

Nagy, F., Vitális, E., Jakab, Á., Borman, A. M., Forgács, L., Tóth, Z., Majoros, L., Kovács, R. L.: In vitro and in vivo effect of exogenous farnesol exposure against Candida auris.
Front. Microbiol. 11, 1-12, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Microbiology

Q1 Microbiology (medical)

17.

Tóth, Z., Forgács, L., Kardos, T., Kovács, R. L., Locke, J. B., Kardos, G., Nagy, F., Borman, A. M., Adnan, A., Majoros, L.: Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species.
J. Fungi. 6 (3), 1-9, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Ecology, Evolution, Behavior and Systematics

Q1 Microbiology (medical)

D1 Plant Science

18.

Tóth, Z., Forgács, L., Locke, J. B., Kardos, G., Nagy, F., Kovács, R. L., Borman, A. M., Majoros, L.: Comparison of killing activity of rezafungin, anidulafungin, caspofungin and micafungin against Candida auris in the presence and absence of serum.
J. Fungi. 5 (95), 130-131, 2019.

DEA

19.

Prépost, E., Tóth, Z., Perlin, D., Gesztelyi, R., Kardos, G., Kovács, R. L., Nagy, F., Forgács, L., Majoros, L.: Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis.
Infect Drug Resist. 12, 1805-1814, 2019.

doi DEA

Journal metrics:

Q2 Infectious Diseases

Q1 Pharmacology

Q2 Pharmacology (medical)

20.

Nagy, F., Tóth, Z., Daróczi, L., Székely, A., Borman, A. M., Majoros, L., Kovács, R. L.: Farnesol increases the activity of echinocandins against Candida auris biofilms.
Med. Mycol. 58 (3), 404-407, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Infectious Diseases

Q1 Medicine (miscellaneous)

D1 Veterinary (miscellaneous)

21.

Nagy, F., Tóth, Z., Bozó, A., Czeglédi, A., Rebenku, I., Majoros, L., Kovács, R. L.: Fluconazole is not inferior than caspofungin, micafungin or amphotericin B in the presence of 50% human serum against Candida albicans and Candida parapsilosis biofilms.
Med. Mycol. 57 (5), 573-581, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Infectious Diseases

Q1 Medicine (miscellaneous)

D1 Veterinary (miscellaneous)

22.

Forgács, L., Tóth, Z., Locke, J. B., Nagy, F., Balázs, B., Prépost, E., Kardos, G., Kovács, R. L., Székely, A., Borman, A. M., Majoros, L.: Frequency of paradoxical and trailing effects with rezafungin, anidulafungin, caspofungin and micafungin against Candida species.
J. Fungi. 5 (95), 131-132, 2019.

DEA

23.

Tóth, Z., Forgács, L., Locke, J. B., Kardos, G., Nagy, F., Kovács, R. L., Székely, A., Borman, A. M., Majoros, L.: In vitro activity of rezafungin against common and rare Candida species and Saccharomyces cerevisiae.
J. Antimicrob. Chemother. 74 (12), 3505-3510, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Infectious Diseases

D1 Microbiology (medical)

D1 Pharmacology

D1 Pharmacology (medical)

24.

Jakab, Á., Tóth, Z., Nagy, F., Nemes, D., Bácskay, I., Kardos, G., Emri, T., Pócsi, I., Majoros, L., Kovács, R. L.: Physiological and transcriptional response of Candida parapsilosis to exogenous tyrosol.
Appl. Environ. Microbiol. 85 (20), 1-12, 2019.

doi DEA WoS Scopus

Journal metrics:

D1 Applied Microbiology and Biotechnology

Q1 Biotechnology

D1 Ecology

D1 Food Science

25.

Kovács, R. L., Nagy, F., Tóth, Z., Bozó, A., Balázs, B., Majoros, L.: Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Lett. Appl. Microbiol. 69 (4), 271-278, 2019.

doi DEA

Journal metrics:

Q2 Applied Microbiology and Biotechnology

Publication list